Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

NAPLEX STUDY > Arrhythmics > Flashcards

Arrhythmics Flashcards

1
Q

Pathway of a heartbeat

A
  1. SA node
  2. R/L atria - atria contract
  3. AV node
  4. Bundle of His > ventricles
  5. right bundle branch
  6. left bundle branch
    purkinje fibers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Arrthymia is caused

A

by a disruption somewhere in the conduction system:
-SA node can be firing at an abnormal rate or rhythm
-Scar tissue from a prior MI
another part of the heart may be acting like a pacemaker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Phase 0

A

rapid ventricular depolarization
-influx of Na = ventricular contraction (represented by the QRS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Phase 1

A

early rapid repolarization
-Na channels close

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phase 2

A

influx of Ca and efflux of K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phase 3

A

rapid ventricular repolarization
efflux of K = ventricular relaxation (T wave)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Phase 4

A

resting membrane potential is established
atrial depolarization occurs (represented by P wave)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

QT prolonging drugs: antiarrhythmics

A

class Ia, Ic, III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

QT prolonging drugs: anti-infectives

A

antimalarials, azole antifungals (all except Cresemba), macrolides, quinolones, lefamulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

QT prolonging drugs: antidepressants

A

SSRIs (escitalopram and citalopram), TCAs, mirtazapine, trazodone, venlafaxine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

QT prolonging drugs: antimetics

A

5-HT3 receptor antagonists, droperidol, metoclopramide, promethazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

QT prolonging drugs: antipsychotics

A

1st gen (haldol, chlorpromazine, thioridazine)
second gen (ziprasidone)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

QT prolonging drugs: oncology medications

A

ADT (leuprolide)
TKI (nilotinib)
Oxaliplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

QT prolonging drugs: other

A

cilostazol, donepezil, fingolimod, hydroxyzine, loperamide, methadone, ranolazine, solifenacin, tacrolimus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Class I

A

Disopyramide, Quinidine, Procainamide
-pro-arrhythmic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Class Ib

A

Lidocaine, Mexiletine
-pro-arrhythmic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Class Ic

A

flecainide, propafenone
-pro-arrhythmic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Class II

A

BB
-slow ventricular rate in AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Class III

A

dronedarone, dofetilide, sotalol, ibutilide, amiodarone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Class IV

A

Verapamil, diltiazem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Way to remember classes of antiarrthymics

A

Double Quarter Pounder
Lettuce Mayo
Fries Please!
Because
Dieting During Stress is always
Very Difficult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Class I: Na channel blockers

A

proarrhythmic

23
Q

Class II: BB

A

slow ventricular rate in AF

24
Q

Class III: K channel blockers

A

-amiodarone and dronedarone block K channels, Ca channels, Na channels, and alpha- and beta-adrenergic receptors
-amiodarone and dofetilide are used for AF in patients with HF

25
Class IV: Ca-channel blockers, non-DHP
slow ventricular rate - DO NOT USE IN PATIENTS WITH HFREF
26
Digoxin
Na-K-ATPase blocjer -decrease HR by enhancing vagal tone and positive iontropy
27
Adenosine
activates adenosine receptors to decrease AV node conduction -used for paroxysmal SVT
28
Valvular AF
AF with moderate to severe mitral stenosis or with mechanical heart valve; long-term anticoagulation with warfarin is indicated
29
Non-valvular
AF without moderate to severe mitral stenosis or mechanical heart valve `
30
Goal resting HR in those with symptomatic AF
<80 BPM
31
Goal for resting HR for those with asymptomatic AF
< 110 BPM
32
Rate control
BB or Non-DHP CCBs (sometimes digoxin in patients with refractory or those who cannot tolerate first line agents)
33
Rhythm control
-restore and maintaine NSR -Class Ia, Ic, or III drug or cardioconversion (must be anti-coagulated before cardioconversion) -if AF is permanent, avoid rhythm-control strategy
34
Stroke ppx
-NOACs are preferred over warfarin for stroke prevention in non-valvular AF -warfarin is indicated for stroke prevention in patients with AF and a mechanical heart valve
35
Amiodarone safety
-pulmonary toxicity -hepatotoxicity -iodine hypersensitivity -Hyper/hypo thyroidism -optic neuropathy -photosensitivity (slate blue skin discoloration) -peripheral neuropathy
36
Amiodarone induced thyroid disorder
inhibits peripheral conversion of T4 to T3
37
Amiodarone infusion
infusions > 2 hours require a non-PVC container (polyolefin or glass); PVC tubing is okay -use 0.22 micron filter, central line preferable -incompatible with heparin (flush line with saline); many Y-site additive incompatibilities
38
Amiodarone and digoxin
decrease digoxin dose by 50%
39
Amiodarone and Warfarin
decrease dose by 30-50%
40
Amiodarone and simvastatin and lovastatin
20 mg TDD of simvastatin and 40 mg TDD of lovastatin
41
amiodarone and sofosbuvir
increases the bradycardiac effect of amiodarone - do not use together
42
Digoxin range for AF
0.8-2 ng/mL
43
when to draw digoxin levels
12-24 hrs after dose
44
digoxin antidote
Digifab
45
What disorders increase the risk of digoxin toxicity
Hypokalemia, hypomagnesemia, and hypercalcemia
46
disopyramide
anticholinergic (myasthenia gravis)
47
Quinidine
take with food or milk -hemolysis (G6PD deficiency) -DILE -Cinchonism - tinnitus, hearing loss, blurred vision, headache, delirium
48
Procainamide
-injection -active metabolite NAPA and is renally cleared -therapeutic level: 4-10 mcg/mL -boxed warning: agranulocytosis, antinuclear antibody (ANA) that leads to DILE -acetylation leading to drug accumulation and toxicity
49
Lidocaine
-injection -refractory VT/cardiac arrest
50
Flecainide
do not use in HF or MI
51
Propafenone
do not use in HF or MI -metallic taste
52
Dronedarone (Multaq)
-increased risk of death, stroke and HF in patients with decompensated HF or permanent AF -Do not use strong CYP3A4 inhibitors and QT prolonging drugs -hepatic failure, pulmonary disease, -does not contain iodine and has little effect on thyroid
53
Sotalol (Betapace AF, Betapace, Sotylize Sorine)
-CrCl < 60 mL change the frequency and adjust dosing to CrCl

NAPLEX STUDY (25 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions